Clinical comprehensive evaluation of desloratadine in the treatment of urticaria
- VernacularTitle:地氯雷他定治疗荨麻疹的临床综合评价
- Author:
Lu LIU
1
;
Lulu ZHEN
2
;
Meijuan REN
2
;
Rui LI
2
;
Chang LIU
1
;
Meixing YAN
1
Author Information
1. Dept. of Pharmacy，Qingdao Women and Children’s Hospital of Qingdao University，Shandong Qingdao 266034，China
2. School of Medicine and Pharmacy，Ocean University of China，Shandong Qingdao 266000，China
- Publication Type:Journal Article
- Keywords:
desloratadine;
loratadine;
urticaria;
clinical comprehensive evaluation;
Delphi method;
analytic hierarchy process
- From:
China Pharmacy
2022;33(10):1240-1246
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To eva luate the clinical comprehensive value of desloratadine in the treatment of urticaria. METHODS The clinical comprehensive evaluation index system based on six dimensions such as safety ，effectiveness，economy，suitability， innovation and accessibility were preliminarily determined by using the methods of literature investigation and expert investigation ； the core contents of the evaluation index system were evaluated and screened by Delphi method and analytic hierarchy process ；the importance of the index was assigned by Likert 5-level scoring method ；the evidence from various sources were collected and qualitative and quantitative integration analysis were conducted according to the clinical comprehensive evaluation index system with the help of system evaluation ，drug instructions ，expert guidelines/consensus ，adverse drug reaction monitoring report ，etc； the experts scored its clinical comprehensive value according to the clinical comprehensive evaluation evidence of each dimension of desloratadine ，combined with the weight of the clinical comprehensive evaluation index system ，the clinical comprehensive evaluation score of the tertiary indexes of desloratadine were calculated. The total clinical comprehensive evaluation score was obtained by accumulating the scores of each index ，and compared with loratadine. RESULTS This study successfully constructed the clinical comprehensive evaluation index system of desloratadine in the treatment of urticaria ，including 6 primary indexes ，13 secondary indexes and 30 tertiary indexes. The total clinical comprehensive evaluation score of desloratadine was 93.63 and that of loratadine was 70.91. CONCLUSIONS The clinical comprehensive value of desloratadine is higher than that of loratadine ，which can provide a reference basis for clinical rational drug use in medical institutions ，selection of drug use catalogue and improvement of national drug policy.
